期刊文献+

重组组织型纤溶酶原激活剂联合依达拉奉治疗急性脑梗死临床疗效观察 被引量:1

Therapeutic efficacy of rtPA-edaravone combination on acute cerebral infarction
下载PDF
导出
摘要 目的观察重组组织型纤溶酶原激活剂(rtPA)联合依达拉奉治疗急性脑梗死的临床疗效及安全性。方法选择25例急性脑梗死病人,同时选择25例具有可比性的病例作为对照组。治疗组给予rtPA联合依达拉奉治疗,对照组给予丹参注射液治疗。以欧洲脑卒中临床神经缺损评分标准(ESS)和Barthel指数进行疗效评定。结果治疗后24h、21d的ESS积分治疗组明显高于对照组,差异有显著性;治疗组疗效明显优于对照组。结论rtPA联合依达拉奉治疗急性脑梗死安全有效,能显著改善患者的预后。 Objective To investigate the therapeutic efficacy and safety of rtPA-edaravone combination on acute cerebral infarction(ACI).Methods Twenty-five cases of ACI were selected for study in comparison with 25 cases with comparability as controls.The patients in treatment group were treated with rtPA-edaravone combination,and patients in control group were only treated with Danshen(Radix Salviae Miltiorrhizae)Injection.The neurologic function deficits of patients in both groups were evaluated by ESS and Barthel index before and after the treatment respectively.Results ESS integral of 24 hours,21 days after treatment was high in treatment group was significantly higher than that of patients in control group.The effective rate of patients in treatment group was significantly higher than that of patients in control group.Conclusion The rtPA-edaravone combination is effective in improvement of neurological function and ability of daily living for patients with acute cerebral infarction within 24 h of onset.
出处 《临床和实验医学杂志》 2008年第1期22-23,共2页 Journal of Clinical and Experimental Medicine
关键词 重组组织型纤溶酶原激活剂(rtPA) 依达拉奉 急性脑梗死 rt-PA Edaravone Acute cerebral infarction
  • 相关文献

参考文献4

二级参考文献19

  • 1Jain KK. Neuroprotection in cerebrovascular disease. Expert Opin Investig Drugs, 2000,9:695
  • 2Tanaka M. Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent. Nippon Yakurigaku Zasshi, 2002, 119:301
  • 3Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis, 2003, 15:222
  • 4Tabrizchi R. Edaravone Mitsubishi-Tokyo. Curr Opin Investig Drugs, 2000,1:347
  • 5Jin YJ, Mima T, Raicu V, et al. Combined argatroban and edaravone caused additive neuroprotection against 15 min of forebrain ischemia in gerbils. Neurosci Res, 2002,43:75
  • 6Tanahashi N, Fukuuchi Y. Treatment of acute ischemic stroke: recent progress. Intern Med, 2002, 41:337
  • 7[1]Grotta J C, Welch KMA, Fagan S C, et al. Clinical deterioration following improvement in the NINDS rt - PA stroke trial.Stroke, 2001,52:661~668.
  • 8[2]Larrue V, Kummer R, Muller A, et al. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator. Stroke, 2001,32:438~441.
  • 9横田慎一 熊毅雄治 内海光朝.A Pharmacokinetic Study of MCI—186,a novel drug for cerebrovascular disease in elderly and young healthy subjects[J].临床药理,1997,28(3):693-702.
  • 10Mizuno A,Umemura K,Nakashima M.Inhibitory effect MCI-186,a free radical scavenger,on cerebral ischemia following rat middle cerebral artery occlusion[J].Gen Pharmacol,1998,30(4)∶575-578.

共引文献632

同被引文献11

  • 1脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15737
  • 2王晓玲,贺淑静.依达拉奉治疗急性脑梗死的疗效观察[J].中国实用神经疾病杂志,2007,10(1):86-87. 被引量:4
  • 3赵峰,姜亚军.自由基与缺血性脑血管病[J].中西医结合心脑血管病杂志,2007,5(2):152-153. 被引量:7
  • 4王彤宇,姜生,林祥灿,田桂玲.重组组织型纤溶酶原激活剂治疗急性脑梗死的疗效分析[J].天津医药,2007,35(3):217-218. 被引量:3
  • 5Martinez-Perez M, Canovas Verge D, Carvajal-Diaz A. Fibrinolytic treatment with tissue plasminogen activator. Outcomes in clinical practice with a multidisciplinary model of intervention[J]. Rev Neurol,2007,45(3) :129-133.
  • 6Mahagne MH. Acute management and secondary prevention of ischemic stroke[J]. Presse Med,2007,36(1 Pt 2) :128-133.
  • 7Wang X, Lo EH. Triggers and mediators of hemorrhagic transformation in cerebral ischemia[J].Mol Neurobiol,2003,28:229-244.
  • 8Yoshida H, Yanai H, Namiki Y, et al. Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury [J]. CNSDrug Rev,2006,12(1):9-20.
  • 9Kitagawa Y. Edaravone in acute ischemic stroke[J].Int Med (Tokyo,Japan),2006,45(5):225-226.
  • 10Mishina M, Komaha Y, Kohayashi S, et al. Administration of free radical scavenger edaravone associated with higher frequency of hem orrhagie transformation in patients with eardiogenie embolism[J].Neurol Med Chir (Tokyo) ,2008,48(7) :292-297.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部